CASI Pharmaceuticals Company Top Insiders

CASI Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.618) % which means that it has lost $0.618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.945) %, meaning that it created substantial loss on money invested by shareholders. CASI Pharmaceuticals' management efficiency ratios could be used to measure how well CASI Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.69. The CASI Pharmaceuticals' current Return On Capital Employed is estimated to increase to -1.97. As of now, CASI Pharmaceuticals' Non Currrent Assets Other are increasing as compared to previous years. The CASI Pharmaceuticals' current Debt To Assets is estimated to increase to 0.39, while Total Assets are projected to decrease to under 49.2 M. The CASI Pharmaceuticals' current Common Stock Shares Outstanding is estimated to increase to about 18.5 M, while Net Loss is projected to decrease to (34.6 M). CASI Pharmaceuticals holds a total of 15.49 Million outstanding shares. CASI Pharmaceuticals shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.93 percent of CASI Pharmaceuticals outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that nearly three hundred twenty thousand seven hundred one invesors are currently shorting CASI Pharmaceuticals expressing very little confidence in its future performance. Some institutional investors establish a significant position in stocks such as CASI Pharmaceuticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CASI Pharmaceuticals, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

CASI Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of (1.84) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (3.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $3.33.

CASI Pharmaceuticals Insider Trading

CASI Pharmaceuticals Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as CASI Pharmaceuticals often depends on how effective the management is. CASI Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CASI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CASI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running CASI Pharmaceuticals' price analysis, check to measure CASI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CASI Pharmaceuticals is operating at the current time. Most of CASI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of CASI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CASI Pharmaceuticals' price. Additionally, you may evaluate how the addition of CASI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.